List of insiders holdings for Protalix BioTherapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| Sheratzki Eyal Director 10% Owner | 2007-01-05 20:27:25 | 0 14,466,319 | 14,466,319 | Form 4 |
| Bio-Cell Ltd 10% Owner | 2014-09-18 17:59:19 | 0 10,066,319 | 10,066,319 | Form 4 |
| Hurvitz Eli Director | 2009-11-13 16:30:40 | 4,898,683 4,898,683 | 9,797,366 | Form 4 |
| Toussia-Cohen Sharon Director 10% Owner | 2007-01-05 20:28:07 | 0 6,556,381 | 6,556,381 | Form 4 |
| Techno-Rov Holdings (1993) Ltd 10% Owner | 2007-01-05 20:28:26 | 0 6,186,046 | 6,186,046 | Form 4 |
| Marathon Investments Ltd. 10% Owner | 2009-09-24 11:00:46 | 4,777,304 0 | 4,777,304 | Form 13G |
| Akirov Alfred Director | 2020-03-30 14:12:47 | 3,332,862 0 | 3,332,862 | Form 13G |
| FROST PHILLIP MD Frost Gamma Investments Trust 10% Owner | 2011-01-20 16:18:28 | 3,076,106 0 | 3,076,106 | Form 13D |
| Bashan Dror PRESIDENT AND CEO | 2024-04-03 17:30:27 | 132,516 2,149,418 | 2,281,934 | Form 4 |
| Dexcel Pharma Technologies Ltd. Oren Dan 10% Owner | 2021-06-15 09:19:55 | 2,034,117 0 | 2,034,117 | Form 13G |
| Camber Capital Management LLC 10% Owner | 2017-02-14 12:01:14 | 1,562,933 0 | 1,562,933 | Form 13G |
| Manor Moshe President & CEO | 2018-09-14 16:30:40 | 1,300,000 0 | 1,300,000 | Form 4 |
| HSIAO JANE PH D Director | 2007-02-02 18:18:06 | 1,134,060 0 | 1,134,060 | Form 4 |
| Shaaltiel Yoseph Executive VP, R&D | 2018-09-14 16:30:18 | 700,000 0 | 700,000 | Form 4 |
| Maimon Yossi VP, Chief Financial Officer | 2018-09-14 16:31:39 | 700,000 0 | 700,000 | Form 4 |
| Rubin Eyal Sr. VP and CFO | 2024-09-24 17:00:09 | 0 669,010 | 669,010 | Form 4 |
| Aviezer David President & CEO | 2012-07-18 16:31:13 | 0 418,000 | 418,000 | Form 4 |
| Katz Iftah VP of Operations | 2007-06-13 15:50:55 | 204,351 0 | 204,351 | Form 4 |
| Almon Einat Brill SVP, Chief Development Officer | 2020-06-08 17:07:44 | 196,995 0 | 196,995 | Form 4 |
| Yanai Shlomo Director | 2014-07-24 16:35:33 | 150,000 0 | 150,000 | Form 4 |
| Palash Tzvi Chief Operating Officer | 2015-05-07 17:23:01 | 125,000 0 | 125,000 | Form 4 |
| Naos Yaron Sr. VP, Operations | 2024-09-24 17:00:07 | 100,000 0 | 100,000 | Form 4 |
| Bronfeld Zeev Director | 2022-09-09 17:01:49 | 100,000 0 | 100,000 | Form 4 |
| Forster Eliot Director | 2023-09-15 16:46:57 | 85,715 0 | 85,715 | Form 4 |
| Hayon Yael VP, Research & Development | 2023-08-17 16:30:28 | 35,115 35,115 | 70,230 | Form 4 |
| Schwartz Aharon Director | 2023-10-03 17:00:32 | 61,676 0 | 61,676 | Form 4 |
| Ben Zvi Shmuel Director | 2023-10-03 17:00:50 | 61,676 0 | 61,676 | Form 4 |
| Bar-Shalev Amos Director | 2023-10-03 17:00:51 | 61,676 0 | 61,676 | Form 4 |
| Melincoff Gwen A Director | 2023-10-03 17:00:54 | 61,676 0 | 61,676 | Form 4 |
| Boudes Pol F Director | 2023-10-03 17:00:58 | 61,676 0 | 61,676 | Form 4 |
| Kornberg Roger D. Director | 2008-09-08 20:26:12 | 50,000 0 | 50,000 | Form 4 |
| Granot David Director | 2020-01-22 17:03:26 | 40,000 0 | 40,000 | Form 4 |
| Lauterbach Sandra Leigh VP, Sales & Commercial Affairs | 2012-07-18 16:40:33 | 0 20,000 | 20,000 | Form 4 |
| Lockshin Curtis Director | 2007-03-29 17:00:07 | 0 0 | 0 | Form 3 |
| Buchris Pinhas Barel Director | 2007-01-05 19:33:15 | 0 0 | 0 | Form 3 |
| Gross Yodfat Harel Director | 2007-07-12 17:12:04 | 0 0 | 0 | Form 3 |